A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-α

Cancer Research

Volumn 59, Issue 8, 1999, Pages 1869-1876

  Bocchinfuso, Wayne P ^a   Hively, Wendy P ^b   Couse, John F ^a   Varmus, Harold E ^b   Korach, Kenneth S ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST HYPERPLASIA; BREAST TUMOR; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENE; VIRUS CARCINOGENESIS;

ANIMALS; BREAST; CELL TRANSFORMATION, VIRAL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GENE DELETION; GENE TRANSFER TECHNIQUES; HYPERPLASIA; MALE; MAMMARY NEOPLASMS, ANIMAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS; RECEPTORS, ESTROGEN; TRANSFORMATION, GENETIC; WNT PROTEINS; WNT1 PROTEIN; ZEBRAFISH PROTEINS;

EID: 0033561743     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. George, F. W., and Wilson, J. D. Sex determination and differentiation. In: E. Knobil, J. D. Neil, L. L. Ewing, G. S. Greenwald, C. L. Markert, and D. W. Pfaff (eds.), The Physiology of Reproduction., Vol. 1, pp. 3-26. New York: Raven Press, 1988.
2. Pike, M. C., Spicer, D. V., Dahmoush, L., and Press, M. F. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol. Rev., 15: 17-35, 1993.
3. Boyd, J. Estrogen as a carcinogen: the genetics and molecular biology of human endometrial carcinoma. In: J. Huff, J. Boyd, and J. C. Barrett (eds.), Cellular and Molecular Mechanisms of Hormonal Carcinogenesis: Environmental Influences, Vol. 394, pp. 151-173. New York: Wiley-Liss, 1996.
4. Tsai, M. J., and O'Malley, B. W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem., 63: 451-486, 1994.
5. Kuiper, G. G. J. M., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J-A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA, 93: 5925-5930, 1996.
6. Mosselman, S., Polman, J., and Dijkema, R. ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett., 392: 49-53, 1996.
7. Tremblay, G. B., Tremblay, A., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Labrie, F., and Giguere, V. Cloning, chromosomal location, and functional analysis of the murine estrogen receptor β. Mol. Endocrinol., 11: 353-365, 1997.
8. Enmark, E., Pelto-Huikko, M., Grandien, K., Lagercrantz, S., Lagercrantz, J., Fried, G., Nordenskjold, M., and Gustafsson, J-A. Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern. J. Clin. Endocrinol. Metab., 82: 4258-4265, 1997.
9. Daniel, C. W., Silberstein, G. B., and Strickland, P. Direct action of 17β-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Res., 47: 6052-6057, 1987.
10. Silberstein, G. B., Van Horn, K., Shymala, G., and Daniel, C. W. Essential role of endogenous estrogen in directly stimulating mammary growth demonstrated by implants containing pure antiestrogens. Endocrinology, 134: 84-90, 1994.
11. Russo, I. H., and Russo, J. Mammary gland neoplasia in long-term rodent studies. Environ. Health Perspect., 104: 938-967, 1996.
12. Kleinberg, D. L. Early mammary development: growth hormone and IGF-1. J. Mammary Gland Biol. Neoplasia, 2: 49-57, 1997.
13. Dotzlaw, H., Leygue, E., Watson, P. H., and Murphy, L. C. Expression of estrogen receptor-β in human breast tumors. J. Clin. Endocrinol. Metab., 82: 2371-2374, 1996.
14. Vladusic, E. A., Hornby, A. E., Guerra-Vladusic, F. K., and Lupu, R. Expression of estrogen receptor β messenger RNA variant in breast cancer. Cancer Res., 58: 210-214, 1998.
15. 2, a functional variant of estrogen receptor β expressed in normal rat tissues. Endocrinology, 139: 1082-1092, 1998.
16. Haslam, S. Z., and Nummy, K. A. The ontogeny and cellular distribution of estrogen receptors in normal mouse mammary gland. J. Steroid Biochem. Mol. Biol., 42: 589-595, 1992.
17. Peterson, O. W., Hoyer, P. E., and van Deurs, B. Frequency and distribution of estrogen-receptor positive cells in normal, non-lactating human breast tissue. Cancer Res., 47: 5748-5751, 1987.
18. Coleman, S., Silberstein, G. B., and Daniel, C. W. Ductal morphogenesis in the mouse mammary gland: evidence supporting a role for epidermal growth factor. Dev. Biol., 127: 304-315, 1988.
19. DiAugustine, R. P., Richards, R. G., and Sebastian, J. EGF-related peptides and their receptors in mammary gland development. J. Mammary Gland Biol. Neoplasia, 2: 109-117, 1997.
20. Nowakowski, B. E., and Maurer, R. A. Multiple Pit-1 binding sites facilitate estrogen responsiveness of the prolactin gene. Mol. Endocrinol., 8: 1742-1749, 1994.
21. Das, R., and Vonderhaar, B. K. Prolactin as a mitogen in mammary cells. J. Mammary Gland Biol. Neoplasia, 2: 29-39, 1997.
22. Nandi, S., Guzman, R. C., and Young, J. Hormones and mammary cancer in mice, rats, and humans: a unifying hypothesis. Proc. Natl. Acad. Sci. USA, 92: 3650-3657, 1995.
23. Tsukamoto, A. S., Grosschedl, R., Guzman, R. C., Parslow, T., and Varmus, H. E. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell, 55: 619-625, 1988.
24. Nusse, R., and Varmus, H. E. Wnt genes. Cell, 69: 1073-1087, 1992.
25. Gavin, B. J., and McMahon, A. P. Differential regulation of the Wnt gene family during pregnancy and lactation suggests a role in postnatal development of the mammary gland. Mol. Cell. Biol., 12: 2418-2423, 1992.
26. Weber-Hall, S. J., Phippard, D. J., Niemeyer, C. C., and Dale, T. C. Developmental and hormonal regulation of Wnt gene expression in the mouse mammary gland. Differentiation, 57: 205-214, 1994.
27. Nusse, R., and Varmus, H. E. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell, 31: 99-109, 1982.
28. Nusse, R., van Ooyen, A., Cox, D., Fung, Y. K. T., and Varmus, H. E. Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature (Lond.), 307: 131-136, 1984.
29. Kwan, H., Pecenka, V., Tsukamoto, A., Parslow, T. G., Guzman, R., Lin, T.-P., Muller, W. J., Lee, F. S., Leder, P., and Varmus, H. E. Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice. Mol. Cell. Biol., 12: 147-154, 1992.
30. Donehower, L. A., Godley, L. A., Aldaz, C. M., Pyle, R., Shi, Y-U., Pinkel, D., Gray, J., Bradley, A., Medina, D., and Varmus, H. E. Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev., 9: 882-895, 1995.
31. Couse, J. F., Davis, V. L., Tally, W. C., and Korach, K. S. An improved method of genomic DNA extraction for screening transgenic mice. Biotechniques, 17: 1030-1032, 1994.
32. Lubahn, D. B., Moyer, J. S., Golding, T. S., Couse, J. F., Korach, K. S., and Smithies, O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. USA, 90: 11162-11166, 1993.
33. Cox, D. R. Regression models and lifetables. J. R. Stat. Soc., B34: 187-220, 1972.
34. Russo, I. H., Tewari, M., and Russo, J. Morphology and development of the rat mammary gland. In: T. C. Jones, U. Mohr, and R. D. Hunt (eds.), Integument and Mammary Glands, pp. 233-252. Berlin: Springer-Verlag, 1989.
35. Couse, J. F., Lindzey, J. K., Grandien, K., Gustafsson, J-A., and Korach, K. S. Tissue distribution and quantitative analysis of estrogen receptor-α (ERα) and estrogen receptor-β (ERβ) messenger ribonucleic acid in the wild-type and ERα-knockout mouse. Endocrinology, 138: 4613-4621, 1997.
36. Cardiff, R. D. The biology of mammary transgenes: five rules. J. Mammary Gland Biol. Neoplasia, 1: 61-73, 1996.
37. Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Madura, J., Godsave, S., Korinek, V., Roose, J., Destree, O., and Clevers, H. XTcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell., 86: 391-399, 1996.
38. Behrens, J., von Kries, J. P., Kuhl, M., Brunn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. Functional interaction of β-catenin with the transcription factor LEF-1. Nature (Lond.), 382: 638-642, 1996.
39. Nusse, R. A versatile transcriptional effector of wingless signaling. Cell., 89: 321-323, 1997.
40. Hunter, T. Oncoprotein networks. Cell, 88: 333-346, 1997.
41. Peifer, M. β-catenin as oncogene: the smoking gun. Science (Washington DC), 275: 1752-1753, 1997.
42. Bocchinfuso, W. P., and Korach, K. S. Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J. Mammary Gland Biol. Neoplasia, 2: 323-334, 1997.
43. Edwards, P. A. W., Hiby, S. E., Papkoff, J., and Bradbury, J. M. Hyperplasia of mouse mammary epithelium induced by expression of the Wnt-1 (int-1) oncogene in reconstituted mammary gland. Oncogene, 7: 2041-2051, 1992.
44. Lin, T-P., Guzman, R. C., Osborn, R. C., Thordarson, G., and Nandi, S. Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice. Cancer Res., 52: 4413-4419, 1992.
45. Sakakura, T. Mammary embryogensis. In: M. C. Neville and C. W. Daniel (eds.), The Mammary Gland: Development, Regulation, and Function., pp. 37-66. New York: Plenum Press, 1987.
46. Cunha, G. R., and Hom, Y. K. Role of mesenchyme-epithelial interactions in mammary gland development. J. Mammary Gland Biol. Neoplasia, 1: 21-35, 1996.
47. Couse, J. F., Curtis, S. W., Washburn, T. F., Lindzey, J., Golding, T. S., Lubahn, D. B., Smithies, O., and Korach, K. S. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol. Endocrinol., 9: 1441-1454, 1995.
48. Ignar-Trowbridge, D. M., Teng, C. T., Ross, K. A., Parker, M. G., Korach, K. S., and McLachlan, J. A. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol. Endocrinol., 7: 992-998, 1993.
49. Aronica, S. M., and Katzenellenbogen, B. S. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Mol. Endocrinol., 7: 743-752, 1993.
50. Pietras, R. J., Arboleda, J., Reese, D. M., Wongvipat, N., Pegram, M. D., Ramos, L., Gorman, C. M., Parker, M. G., Sliwkowski, M. X., and Slamon, D. J. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene., 10: 2435-2446, 1995.
51. Ignar-Trowbridge, D. M., Pimentel, M., Parker, M. G., McLachlan, J. A., and Korach, K. S. Peptide growth factor-cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology, 137: 1735-1744, 1996.
52. Lee, A. V., Weng, C-N., Jackson, J. G., and Yee, D. Activation of estrogen receptor-mediated gene transcription by IGF-1 in human breast cancer cells. J. Endocrinol., 152: 39-47, 1997.
53. Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., Metzger, D., and Chambon, P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science (Washington DC), 270: 1491-1494, 1995.
54. Bunone, G., Briand, P-A., Miksicek, R. J., and Picard, D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J., 15: 2174-2183, 1996.
55. Tremblay, A., Tremblay, G. B., Labrie, C., Labrie, F., and Giguere, V. EM-800, a novel antiestrogen, acts as a pure antagonist of the transcriptional functions of estrogens receptors α and α. Endocrinology, 139: 111-118, 1998.
56. Eddy, E. M., Washburn, T. F., Bunch, E. H., Goulding, E. H., Gladen, B. C., Lubahn, D. B., and Korach, K. S. Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology, 137: 4796-4805, 1996.
57. Lindzey, J., and Korach, K. S. Developmental and physiological effects of estrogen receptor gene disruption in mice. Trends Endocrinol. Metab., 8: 137-145, 1997.
58. Lefebvre, P., Berard, D. S., Cordingley, M. G., and Hager, G. L. Two regions of the mouse mammary tumor virus long terminal repeat regulate the activity of its promoter in mammary cells. Mol. Cell. Biol., 11: 2529-2537, 1991.
59. Otten, A. D., Sanders, M. M., and McKnight, G. S. The MMTV LTR is induced by progesterone and dihydrotestosterone but not by estrogen. Mol. Endocrinol., 2: 143-147, 1988.
60. Mymryk, J. S., and Archer, T. K. Dissection of progesterone receptor-mediated chromatin remodeling and transcriptional activation in vivo. Genes Dev., 9: 1366-1376, 1995.
61. Key, T. J. A., and Pike, M. C. The role of oestrogens and progestogens in the epidemiology and prevention of breast cancer. Eur. J. Cancer Clin. Oncol., 24: 29-43, 1988.
62. Castles, C. G., and Fuqua, S. A. W. Alterations within the estrogen receptor in breast cancer. In: J. R. Pasqualini and B. S. Katznellenbogen (eds.), Hormone-dependent Cancer, pp. 81-105. New York: Marcel Dekker, Inc., 1996.